Clincosm LogoSign in Get a demo

chronic spontaneous urticaria

Showing 26 - 46 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Spontaneous Urticaria Trial (Cohort 1: TLL018 tablets, Cohort 2: TLL018 tablets, Cohort 3: TLL018 tablets)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Cohort 1: TLL018 tablets
  • +2 more
  • (no location specified)
May 10, 2022

Chronic Spontaneous Urticaria Trial (Ligelizumab)

No longer available
  • Chronic Spontaneous Urticaria
  • (no location specified)
May 6, 2022

Chronic Spontaneous Urticaria Trial in Germany, Poland, United States (LY3454738, Placebo)

Terminated
Has Results
  • Chronic Spontaneous Urticaria
  • Bakersfield, California
  • +24 more
Feb 14, 2022

Chronic Spontaneous Urticaria, Recurrent Angioedema Trial in Germany (Dupilumab, Placebo)

Completed
  • Chronic Spontaneous Urticaria
  • Recurrent Angioedema
  • Marburg, Hessen, Germany
  • +5 more
Feb 1, 2022

Chronic Spontaneous Urticaria Trial (Remibrutinib)

Available
  • Chronic Spontaneous Urticaria
  • (no location specified)
Dec 9, 2021

STOP CSUA: phySical acTivity, mOod and sleeP in Chronic

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Physical activity monitoring - Symptom monitoring
  • Dublin, Ireland
    St. James's Hospital
Dec 13, 2021

Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab)

Completed
Has Results
  • Chronic Spontaneous Urticaria
  • Ligelizumab
  • Birmingham, Alabama
  • +66 more
Oct 7, 2021

Chronic Spontaneous Urticaria Trial in Warszawa (CT-P39, EU-approved Xolair)

Recruiting
  • Chronic Spontaneous Urticaria
  • CT-P39
  • EU-approved Xolair
  • Warszawa, Poland
    Klinika Ambroziak ESTEDERM
Aug 25, 2021

Chronic Spontaneous Urticaria Trial (Tirabrutinib, Placebo)

Withdrawn
  • Chronic Spontaneous Urticaria
  • (no location specified)
Jul 22, 2021

Chronic Spontaneous Urticaria Trial (SYN008, Omalizumab for injection)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • SYN008
  • Omalizumab for injection
  • (no location specified)
Jun 22, 2021

Chronic Spontaneous Urticaria Trial in Changsha (Recombinant human interleukin-2 (rhIL-2), Control group)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Recombinant human interleukin-2 (rhIL-2)
  • Control group
  • Changsha, Hunan, China
    The Second Xiangya Hospital of Central South University
May 15, 2021

Chronic Spontaneous Urticaria Trial in Grenoble (association of levocetirizine and tranexamic acid, Levocetirizine only)

Recruiting
  • Chronic Spontaneous Urticaria
  • association of levocetirizine and tranexamic acid
  • Levocetirizine only
  • Grenoble, France
    CHU Grenoble-Alpes
Apr 27, 2021

Chronic Spontaneous Urticaria Trial in Worldwide (QGE031, Omalizumab, Placebo)

Completed
Has Results
  • Chronic Spontaneous Urticaria
  • QGE031
  • +2 more
  • Birmingham, Alabama
  • +81 more
Dec 9, 2020

Chronic Spontaneous Urticaria Trial in China (Omalizumab, Placebo)

Completed
Has Results
  • Chronic Spontaneous Urticaria
  • Beijing, Beijing, China
  • +26 more
Nov 3, 2020

Chronic Spontaneous Urticaria, Angioedema Trial in Germany (Omalizumab, Placebo)

Completed
Has Results
  • Chronic Spontaneous Urticaria
  • Angioedema
  • Omalizumab
  • Placebo
  • Mannheim, Baden-Wuerttemberg, Germany
  • +24 more
Aug 21, 2020

Frequency of Parasite Infestation in Chronic Spontaneous

Completed
  • Chronic Spontaneous Urticaria
  • Parasitic Disease
  • Examination of stool samples
  • Basel, Switzerland
    University Hospital Basel
Mar 16, 2020

CHRONIC SPONTANEOUS URTICARIA Trial in France (OMALIZUMAB)

Completed
Has Results
  • CHRONIC SPONTANEOUS URTICARIA
  • Paris Cedex 10, Cedex 10, France
  • +28 more
Feb 11, 2020

Chronic Spontaneous Urticaria Trial in Istanbul (ShotBlocker®, Placebo group)

Completed
  • Chronic Spontaneous Urticaria
  • ShotBlocker®
  • Placebo group
  • Istanbul, Uskudar, Turkey
    University of Health Sciences
Dec 25, 2019

Chronic Spontaneous Urticaria Trial (Levocetirizine (as levocetirizine diHCl), 5mg ( then 20 mg) per day . Oral administration.,

Completed
  • Chronic Spontaneous Urticaria
  • Levocetirizine (as levocetirizine dihydrochloride), 5mg ( then 20 mg) per day . Oral administration.
  • Levocetirizine, (as levocetirizine dihydrochloride) 20 mg ( then 5 mg) per day. Oral administration.
  • (no location specified)
Sep 17, 2018

Chronic Spontaneous Urticaria Trial in Worldwide (omalizumab)

Completed
Has Results
  • Chronic Spontaneous Urticaria
  • Pilar, Buenos Aires, Argentina
  • +34 more
Aug 15, 2018

Chronic Urticaria, Chronic Idiopathic Urticaria, Chronic Spontaneous Urticaria Trial in Bern (Omalizumab (Xolair), Placebo)

Completed
  • Chronic Urticaria
  • +2 more
  • Omalizumab (Xolair)
  • Placebo
  • Bern, Switzerland
    Department of Rheumatology, Clinical Immunology and Allergology,
Apr 14, 2014